News Category
Catherine Cifuentes-Rojas releases a free early-stage go/no-go checklist for biotherapeutics teams to help them make data-driven decisions and avoid c...
VERAXA Biotech (NASDAQ: VRXA) is expanding its use of human-relevant preclinical testing methods across its antibody-based cancer drug programs, aimin...
Quantum BioPharma's agreement with Thermo Fisher's clinical research business moves its investigational progressive MS drug Lucid-MS toward Phase 2 im...
A dual-targeting antibody achieved profound effects in mice across multiple tumor types, offering a potential path to expand immunotherapy's reach to ...
Regentis Biomaterials is advancing GelrinC, a cell-free hydrogel implant that has demonstrated superior pain relief and cartilage repair quality versu...
Annovis Bio CEO Maria Maccecchini will present at two November conferences, highlighting the company's clinical programs and upcoming milestones for i...
Oncotelic is advancing its PLA-guided discovery engine from a published, independently validated four-gene liver cancer survival signature toward a 10...
TransCode Therapeutics has initiated a formal strategic review to evaluate options for maximizing the value of its oncology portfolio, including lead ...
Enodia Therapeutics has named Henrik Torp Nielsen as Chief Financial Officer to steer its financial strategy as the company advances its proprietary S...
Certified-PEP has published a 2026 comparison of 10 research peptide suppliers, revealing significant differences in documentation and transparency th...
A Phase 3 trial shows that combining two immunotherapy drugs extends median survival in patients with a deadly form of lung cancer, signaling a potent...
VolitionRx's nonbinding LOI with Missionpharma aims to develop and commercialize a low-cost, finger-prick NETosis test for neonatal sepsis, potentiall...
Creative Biolabs is spotlighting functional complement assays and microfluidic droplet generation tools that help researchers address assay variabilit...
NanoViricides' Phase IIA trial of NV-387 Oral Gummies for Ebola Bundibugyo is progressing, with Phase IIB anticipated, offering a potential oral treat...
A mutated flu virus spreading early on the West Coast has prompted urgent vaccination calls and highlighted the role of decentralized testing tools fr...
Tonix Pharmaceuticals' Phase 3 RELIEF and RESILIENT studies demonstrate that TONMYA significantly improves pain, symptom severity, and physical functi...
GeoVax Labs has entered into a $1 million revolving loan agreement with Bowery Consulting Group, which includes the appointment of three new directors...
Creative Biolabs has introduced an integrated OMV and exosome-boosted CAR-T development platform to help researchers address poor infiltration, immuno...
Creative Biolabs highlights its tumor organoid and immune cell co-culture services, including CAR-T models, to address limitations of 2D cultures in i...
GeoVax Labs has entered a $1 million revolving loan agreement with Bowery Consulting Group, which includes board restructuring that gives the lender s...
TransCode Therapeutics' TTX-MC138 met its primary safety endpoint in Phase 1a trials, with no dose-limiting toxicities and early signs of disease stab...
Oncotelic Therapeutics announced a peer-reviewed study showing its AI platform identified a four-gene prognostic signature in liver cancer, which coul...
Tonix Pharmaceuticals will report third-quarter 2026 financial results on Nov. 9, giving investors a key update on the commercial rollout of its newly...
Coherence Neuro's $45 million Series A, backed by Peter Thiel and OpenAI, will fund the first chronic human trial of its SOMA implant for glioblastoma...
Adaptogenics Health Corp. is advancing a three-part business model combining peptide supply, proprietary therapeutics, and drug delivery technologies ...
Neovii Pharmaceuticals is advancing its FDA Fast Track-designated ATLG program into a pivotal Phase 2 study for Type 1 Diabetes and appointing Dr. Sal...
Annovis Bio will present three buntanetap-focused sessions at the 2026 CTAD conference, highlighting its mechanism, pivotal Phase 3 trial design, and ...
NeuroThera Labs has completed manufacturing and obtained European QP batch release certification for its SCI-110 investigational drug, enabling shipme...
VERAXA Biotech is implementing New Approach Methodologies across its preclinical cancer research, aiming to generate more clinically relevant data whi...
VERAXA Biotech is advancing its BiTAC platform to develop antibody-based cancer therapies that aim to improve treatment selectivity and reduce toxicit...
The United States retains a narrow biotechnology lead over China, but a new SCSP scorecard warns that China's industrial capacity and national leverag...
SS Innovations International has launched Sri Lanka's first robotic cardiac surgery program at Kings Hospital Colombo using its SSi Mantra 3.0 system,...
Regentis Biomaterials is scaling production of its GelrinC cartilage repair implant after European approval of a solvent-free process that increases y...
Quantum BioPharma's Unbuzzd clinical trial results were highlighted in Men's Fitness, drawing attention to the company's alcohol recovery formulation ...
Scinai Immunotherapeutics announced a surge in committed CDMO orders to $8.1 million, backed by a $5.3 million financing that extends its cash runway ...
Bangladesh's 200,000 suspected measles cases highlight the global risk of falling vaccination rates and the need for sustained public health efforts.
NanoViricides reports positive juvenile animal safety results for its broad-spectrum antiviral NV-387, potentially enabling pediatric clinical trials ...
VERAXA Biotech is implementing New Approach Methodologies across its preclinical programs to generate more human-relevant data and reduce animal testi...
Pentixapharm reports growing international evidence for Pentixafor PET in primary aldosteronism, reinforcing the rationale for its pivotal Phase 3 PAN...
Quantum BioPharma's Unbuzzd alcohol recovery formulation gained mainstream attention through a Men's Fitness article, but the mixed clinical trial res...
A small German study finds that a new therapeutic vaccine kept two-thirds of patients with aggressive brain tumors alive after eight years, with 42% e...
TransCode Therapeutics will present updated Phase 1a clinical data for its lead candidate TTX-MC138 at the ESMO Congress 2026, highlighting progress i...
Tonix Pharmaceuticals will present new data on its recently approved fibromyalgia drug TONMYA at the 2026 IASP World Congress on Pain, highlighting th...
A new study reveals that ISAba1-mediated amplification of the crp-osmC gene cluster enhances Acinetobacter baumannii's ability to colonize and survive...
New research shows that measles can cause lasting immune damage, making survivors more susceptible to other infections, underscoring the importance of...
Creative BioTherapeutics has been named a 2026 Prix Galien USA Best Startup nominee for its preclinical biologic CBT300, highlighting the urgent chall...
HeartBeam's participation in a 27.6 million euro European cardiovascular research consortium and its leadership of the HEART-CHECK study could acceler...
Helus Pharma appoints Suresh Durgam, a veteran with over 20 years of CNS drug development experience, to its board of directors, a move that could str...
